关于急性严重性结肠炎的未来 - - 一篇叙述性评论
Leshni Pillay1, Janakan Selvarajah1, Bridgette Andrew1
1Department of Gastroenterology, Royal Melbourne Hospital, Parkville, Melbourne 3052, Australia.
Journal of clinical medicine
|January 8, 2025
概括
皮质类固醇可以降低急性严重性结肠炎 (ASUC) 死亡率,但有副作用. 需要更安全的无类固醇疗法,但缺乏高质量的试验来比较当前的选择.
科学领域:
- 胃肠病学 胃肠病学
- 内部医学 内部医学
- 临床药理学 临床药理学
背景情况:
- 皮质类固醇显著降低了急性严重性结肠炎 (ASUC) 死亡率.
- 然而,皮质类固醇与显著的副作用有关,高达30%的患者表现出耐固醇ASUC.
- 这就需要开发更安全,更有效的ASUC疗法.
研究的目的:
- 提供当前ASUC管理策略的最新审查.
- 基于现有的临床试验和数据,设想未来的ASUC无类固醇治疗模式.
- 突出需要对救援疗法和新药进行高质量的比较研究.
主要方法:
- 对ASUC治疗的当前文献和临床试验数据的综述.
- 现有和新兴ASUC疗法的有效性和安全性分析.
- 评估新药在对抗类固醇耐药ASUC的治疗中的作用.
主要成果:
- 尽管ASUC的治疗仍然严重依赖于皮质类固醇,尽管它们具有不良影响.
- 因弗利克西马布和环素有大量支持其使用的数据,但对抗皮质类固醇作为初始治疗的对头试验缺席.
- 新型治疗药物为口服治疗选择提供了潜在的可能性,但需要进一步的前性数据.
结论:
- 目前的ASUC管理仍然在很大程度上依赖于皮质类固醇,由于副作用,需要探索替代品.
- 虽然infliximab和cyclosporine已被确立为救援疗法,但对初始皮质类固醇治疗缺乏前性比较数据.
- 新兴的新疗法,包括口服选择,显示出希望,但在ASUC治疗中广泛采用之前需要强大的前性数据.
相关概念视频
01:27Inflammatory Bowel Disease I: Ulcerative Colitis
135
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
135
01:21Inflammatory Bowel Disease V: Surgical Management
116
Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
Here are some common surgical interventions for IBD:
116
01:29Drugs for Treatment of Ulcerative Colitis in IBD
119
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
119
01:30Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
315
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
315
01:17Chronic Bowel Disorders: Introduction
386
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
386
01:29Inflammatory Bowel Disease IV: Pharmacological Management
110
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
110